CC-92328

N/A

Report date: 2025/04/07 14:32:50

Base Information

Drug NameCC-92328

Drug Alias NameCC-92328

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionImmunologic cytotoxicityNatural killer cells stimulants

TargetsUpdating

Therapy Area/IndicationsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited StatesSpain

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCelgene Corp

Active IndicationsN/A

Inactive IndicationsMultiple Myeloma

ATC CodeN/A